Tue.Nov 22, 2022

The next era of Greater Boston’s biotech boom

PharmaVoice

How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth

100
100

How Clinical Trials Can Thrive in the Digital Era

PharmExec

The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.

How bacteria-enabled technology for wounds could also help cancer patients

PharmaVoice

Evelina Vågesjö, co-founder and CEO of the immunotherapy company Ilya Pharma, is working on a new modality to speed wound healing

How Banks and Credit Unions Are Getting Serious About Culture Change and Employee Engagement

Integrity Solutions

With employee turnover one of the most serious internal threats credit unions and banks face today, many forward-thinking financial institutions are taking a hard look at their organizations culture and opportunities to change.

Beware of a False Sense of Cybersecurity

MedCity News

Based on some independent research that my company commissioned with more than 200 companies, we came to several conclusions that are highlighted in the article. Broadly, however, it signals the false sense of (cyber)security that many companies are currently harboring.

New View Surgical, Inc. Closes $12.1M Series B-1 Financing, Readies Limited Market Release of its VisionPort™ System For Minimally Invasive Surgery

Legacy MEDSearch

New View Surgical, Inc., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), announced the closure of a $12.1M Series B-1 equity financing round to fund the commercialization of its VisionPort System.

More Trending

Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck

Fierce Pharma

Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck. fkansteiner. Tue, 11/22/2022 - 10:07

Horizon Launches Suite of Behavioral Health Solutions for Health Plans, Health Systems

MedCity News

NovaWell, the behavioral health affiliate of Horizon Healthcare Services, is offering four solutions for health plans and health systems. The program was created from Horizon’s own success in New Jersey.

Umoja and IASO partner to develop therapies for haematological malignancies

Pharmaceutical Technology

Umoja Biopharma has signed a research agreement with IASO Biotherapeutics (IASO Bio) to develop off-the-shelf therapies for haematological malignancies.

Heard at HLTH: What’s on Healthcare Executives’ Agenda for 2023? [Sponsored]

MedCity News

At the 5th annual HLTH conference in Las Vegas, 14 healthcare executives from companies such as Babson Diagnostics to Wheel responded to questions such as what’s the difference between a positive and negative user experience in telehealth? They also previewed their plans for 2023.

Literature Monitoring: A Critical Tool for Pharmacovigilance in Life Sciences

Copyright Clearance Center

The post Literature Monitoring: A Critical Tool for Pharmacovigilance in Life Sciences appeared first on Copyright Clearance Center. CCC in the News

63

What Health Systems Need to Understand About Home Care, per Medically Home’s CMO

MedCity News

Home care is no longer only for elderly patients who require a visiting nurse to come into their home and check on them post-discharge.

GSK will pull Blenrep from US market after failed trial

Pharma Phorum

GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market.

At HLTH 2022, a New Chapter for AI [Sponsored]

MedCity News

Machine learning algorithms have reached a familiar milestone in the healthcare industry –in order for them to be more widely embraced by providers, different approaches to roadtesting and validating them are underway.

Clinical trials authorised for 3D-printed ulcerative colitis drug

European Pharmaceutical Review

Triastek, Inc.

HC9 Ventures Launches with $83M Fund, Aiming to Be ‘More Than Another Name in a Press Release’

MedCity News

A new venture capital firm named HC9 Ventures recently launched and announced the close of a $83 million fund. It is led by three healthcare industry veterans, and its more than 125 investors are “intentionally and only healthcare executives,” according to HC9 Co-Founder Richard Lungen.

Using UHPLC-MS/MS for trace detection of ?-lactam antibiotics

European Pharmaceutical Review

A paper, published in Molecules , has developed validated the use of ultra-performance liquid chromatography with triple quadrupole mass spectrometry, or UHPLC-MS/MS, for identification and detection of the ?-lactams lactams cephapirin and ceftiofur in cleaning solutions of the production reactors.

How Papa Is Driving Results in Companion Care

MedCity News

A series of recently released studies on Papa, a companion care company, found that the startup reduced emergency department visits, decreased healthcare spending and improved loneliness. Consumer / Employer Daily SYN Top Story Companion HLTH Papa senior care

'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says

Fierce Pharma

Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says. kdunleavy. Tue, 11/22/2022 - 11:13

Japan grants emergency regulatory approval for Shionogi’s Covid-19 drug

Pharmaceutical Technology

The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted emergency regulatory approval for Shionogi ’s new anti-SARS-CoV-2 drug, Xocova (ensitrelvir fumaric acid, S-217622), for Covid-19.

Merck's Keytruda tees up BMS stomach cancer fight with new trial win

Fierce Pharma

Merck's Keytruda tees up BMS stomach cancer fight with new trial win. zbecker. Tue, 11/22/2022 - 11:04

Attention Healthcare Startups: Register for INVEST and Apply Now to Be Part of Pitch Perfect 2023

MedCity News

We’re now accepting applications for INVEST Pitch Perfect, scheduled for May 22-24 at the Ritz Carlton in Chicago.

Magazine: What Rishi Sunak can do for the UK pharma industry

Pharmaceutical Technology

It's the last issue of Pharmaceutical Technology Focus in 2022, and a lot of changes have occurred over the year, not just in the pharma space, but also from a geopolitical, financial and energy perspective.

Merck to acquire Imago for $1.35 billion

European Pharmaceutical Review

Merck has announced it will acquire biopharma Imago BioSciences, Inc for around $1.35

Two Years After Winning Accelerated Approval, GSK Pulls Blenrep At FDA’s Request

Pharma Leaders

Two years after its blood cancer treatment Blenrep (belantamab mafodotin) won accelerated approval from the FDA, GSK has removed the drug from the market in the U.S. at the FDA’s request. Compliance Channel Posts

ChoiceSpine™ Announces Line Extension of their Harrier™ Stand-Alone Anterior Lumbar Interbody Fusion System

Legacy MEDSearch

ChoiceSpine LLC, a privately-held spinal device manufacturer based in Knoxville, TN, announces the launch of an additional lordotic offering for their stand-alone anterior lumbar interbody – Harrier SA.

Scott Burrows, Inspirational Healthcare Speaker

Scott Burrows

The Healthcare Worker Shortage is Real. What Can Be Done About It? As an inspirational healthcare speaker, I know that it is never easy to deliver bad news. However, as we near 2023, the news is dismal.

Graybug, CalciMedica sign agreement to create new biopharmaceutical company

Pharma Leaders

Expected to be funded using nearly $35m of cash and cash equivalents at closing, the combined company will focus on advancing CalciMedica’s pipeline of first-in-class product candidates.

Advancing PV Operations and Patient Safety through Innovation

Pharmaceutical Commerce

How digital adoption is driving pharmacovigilance.

Thankful + Grateful — For You!

Modus

It's that time of year, when we tend to reflect upon the past year and look ahead at the coming year. But most of all, we’d like to express our gratitude and thankfulness to all of you—whether you’re a customer, partner, or just a friend of Modus—you’re appreciated more than you know!

Sales 52

FDA priority review for AbbVie lymphoma bispecific antibody

European Pharmaceutical Review

The US Food and Drug Administration ( FDA ) has accepted priority review of AbbVie’s Biologics License Application of epcoritamab (DuoBody®-CD3xCD20), an investigational subcutaneous bispecific antibody (BsAb), for adults with relapsed/refractory large B-cell lymphoma (LBCL) after two or more lines of systemic therapy.

Elon Musk, pharma, and the future of Twitter

Pharma Phorum

Musk’s arrival at the social platform has raised questions for users, which includes pharma companies who use Twitter for marketing and patients who utilise it to engage with their medical communities.

What Doctors Expect from Medical Sales Reps

MedReps

While some may view pharmaceutical sales as easy, there are a number of things that happen behind the scenes in order to make those sales visits with doctors go well. A medical sales rep needs to be as prepared as possible and have all of the information doctors want in order to make a sale.

Swing’s digital therapy for fibromyalgia hits the right beat

Pharma Phorum

Patients with fibromyalgia – a common condition causing chronic pain, fatigue, poor sleep, and cognitive dysfunction – could get relief from a digital therapeutic (DTx) based on cognitive behavioural therapy, according to a clinical trial.